Heron Therapeutics, Inc. (HRTX)
0.7459
-0.04
(-4.82%)
USD |
NASDAQ |
Mar 30, 16:00
0.7599
+0.01
(+1.88%)
After-Hours: 20:00
Heron Therapeutics EPS Diluted (Quarterly) : -0.0157 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.954M |
| Revenue (Quarterly) | 40.59M |
| Total Expenses (Quarterly) | 43.54M |
| Enterprise Value | 235.69M |
| Gross Profit Margin (Quarterly) | 72.61% |
| Profit Margin (Quarterly) | -7.28% |
| Earnings Yield | -16.16% |
| Normalized Earnings Yield | -9.626 |